Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

Melanoma in the Fire Service - an Occupation We Need to Target for S…

Christine Kannler

Overview of Skin Cancers for General Practitioners

Tarek Haykal

Year in Review 2024 - Melanoma

Oncology 2024 Year in Review

A. van Akkooi

Year in Review 2024 - Key Updates in Melanoma Treatment

Oncology 2024 Year in Review

T. Haykal

Biomarkers for Immunotherapy in Melanoma: Where Are We Now?

Vanderbilt University Medical Center (VUMC)

D. Johnson

Lynch Syndrome and Skin: A Dermatologist’s Perspective

Dana-Farber Cancer Institute

V. Nambudiri

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Oncology Data Advisor

M. Hadfield

Systemic Therapy for HER2+ mBC With CNS Involvement

Total Health

E. Cobain

Year in Review 2024 - Top Clinical Trials in Neuro-Oncology

Oncology 2024 Year in Review

S. Bagley

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Role of Nivolumab/Relatlimab in the 1L Treatment Landscape for Metas…

Rodabe Amaria

Medical Treatments for Melanoma: Current and Future Options

Melanoma Research Foundation

F. Collichio

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

S. Patel

The Latest and Greatest in Melanoma Treatment, 2024: From Adjuvant t…

Melanoma Research Foundation

K. Margolin

EGFR-Mutated Lung Cancer: CNS Metastases Co-Mutations & Treatment

GRACE

I. Dagogo-Jack, J. Rotow, M. Shields, A. Cooper, A. Qin

Optimal Therapy Sequence for 1L Treatment of BRAF-Mutated Metastatic…

Stanford Medicine

A. Betof Warner

ESMO 2024 Summary: Metastatic Melanoma Highlights

2024 ESMO Annual Meeting Insights Hub

C. Blank

Understanding TIL Cell Therapy and the Patient Journey for Advanced …

Melanoma Research Foundation

J. Lutzky

Most Important Melanoma Treatment Updates From 2024

OncoAlert

A. Betof Warner